Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new publication citation for the HIMALAYA five-year survival update was added, and the page revision tag updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check8 days agoChange DetectedThe Taiwan recruitment locations were updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed site/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor update to the ClinicalTrials.gov site itself rather than any change to the study record.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Naples, Italy as a location and removed Napoli, Italy from the study locations.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Hepatocellular carcinoma keyword and Genetic and Rare Diseases Information Center resource. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.